The Turkish Torku-Sekerspor team has confirmed its 14-rider roster which includes the signings of Kevin Seeldraeyers and Tomasz Marczynski. However, there is no room for Juan Jose Cobo in the team that is now led by Lionel Marie.

Lionel Marie, former sports director of Giant-Shimano, Garmin-Sharp, Orica-GreenEdge and Cofidis, takes the reins of the Turkish Torku-Sekerspor team. Kevin Seeldraeyers and Tomasz Marczinski arrive from Wanty-Group Gobert and CCC, respectively, and are expected to be the team leaders in 2015.

11 riders from 2014 will stay with the team: Nazym Bakirci, Miraç Kal, Amhet Örken, Amhet Akdilek, Muhammed Atalay, Bekir Baki Arkirsa, Rasim Reis, Feritcan Samli, Fettulah Köse, Fatih Keles and Ukrainian Sergiy Grechyn. Ismail Aksoy is the final new signing.

However, Spaniard Juan Jose Cobo and Davde de la Fuente have not been retained. The latter has joined the Portuguese Efapel team while there is no news about a new team for the 2011 Vuelta a Espana champion.

Cobo made his debut with Saunier Duval in 2004 and has had a career with numerous ups and dows. His talents were revealed in 2007 when he won the Vuelta al Pais Vasco. One year later he seemed to confirm his potential in the Tour de France after he finished second in the mountain stage to Hautacam behind his teammate Leonardo Piepoli who has later been disqualified. However, the team was ejected from the race after the doping scandal surrounding Riccardo Ricco. Later he won a stage in the 2009 Vuelta and after a poor year with Caisse d'Epargne, he became a surprise winner of the 2011 Vuelta when he beat Chris Froome and Bradley Wiggins while wearing the Geox jersey. However, his two years with Movistar were a big failure. In 2014, he rode for Torku and was sixth in the Tour of Turkey and 13th in the Tour of Azerbaijan.

The Torku Sekerspor recently joined the Movement For a Credible Cycling MPCC on probation after Ivailo Gabrovskiy and Mustafa Sayar who won the Tour of Turkey in 2012 and 2013 respectively, have both tested positive for EPO.